Insight Molecular Diagnostics Inc.

Our principal executive and administrative offices are located in Irvine, California, under a lease arrangement. The Irvine lease includes approximately 26,800 square feet of rentable space and expires on October 31, 2027. Effective in September 2023, we entered into a sublease agreement with a subtenant to initially sublet approximately 13,400 square feet of rentable space. In June 2025, the portion of the Irvine lease that is subleased will automatically increase to include the remaining portion of the premises, which consists of approximately 13,400 square feet of additional rentable space for a term that will continue to the expiration of the Irvine lease on October 31, 2027. The sublease agreement is subject and subordinate to the Irvine lease.

We operate a CLIA-certified laboratory and have additional office space in Nashville, Tennessee, under lease arrangements. The Nashville leases include 10,681 square feet of rentable space and expires in January 2027. We also have a research and development facility in Göttingen, Germany.

See Note 6 to our consolidated financial statements included elsewhere in this Report for additional information regarding our lease arrangements and properties.